Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by jacques.colinge
Group name EquipeJC
Item Type Journal Article
Title The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia
Creator Sharif et al.
Author O. Sharif
Author R. Gawish
Author J. M. Warszawska
Author R. Martins
Author K. Lakovits
Author A. Hladik
Author B. Doninger
Author J. Brunner
Author A. Korosec
Author R. E. Schwarzenbacher
Author T. Berg
Author R. Kralovics
Author J. Colinge
Author I. Mesteri
Author S. Gilfillan
Author A. Salmaggi
Author A. Verschoor
Author M. Colonna
Author S. Knapp
Abstract Phagocytosis and inflammation within the lungs is crucial for host defense during bacterial pneumonia. Triggering receptor expressed on myeloid cells (TREM)-2 was proposed to negatively regulate TLR-mediated responses and enhance phagocytosis by macrophages, but the role of TREM-2 in respiratory tract infections is unknown. Here, we established the presence of TREM-2 on alveolar macrophages (AM) and explored the function of TREM-2 in the innate immune response to pneumococcal infection in vivo. Unexpectedly, we found Trem-2(-/-) AM to display augmented bacterial phagocytosis in vitro and in vivo compared to WT AM. Mechanistically, we detected that in the absence of TREM-2, pulmonary macrophages selectively produced elevated complement component 1q (C1q) levels. We found that these increased C1q levels depended on peroxisome proliferator-activated receptor-delta (PPAR-delta) activity and were responsible for the enhanced phagocytosis of bacteria. Upon infection with S. pneumoniae, Trem-2(-/-) mice exhibited an augmented bacterial clearance from lungs, decreased bacteremia and improved survival compared to their WT counterparts. This work is the first to disclose a role for TREM-2 in clinically relevant respiratory tract infections and demonstrates a previously unknown link between TREM-2 and opsonin production within the lungs.
Publication PLoS Pathog
Volume 10
Pages e1004167
Date Jun 2014
Journal Abbr PLoS pathogens
DOI 10.1371/journal.ppat.1004167
ISSN 1553-7374 (Electronic) 1553-7366 (Linking)
Tags *Disease Models, Animal, Animals, Apoptosis, Cell Line, Transformed, Cells, Cultured, Complement C1q/genetics/*metabolism, Cytokines/metabolism, Female, Lung/cytology/*immunology/metabolism/pathology, Macrophages, Alveolar/*immunology/metabolism/pathology, Male, Membrane Glycoproteins/genetics/*metabolism, Mice, Inbred C57BL, Mice, Knockout, Neutrophil Infiltration, original, Phagocytosis, Pneumonia, Pneumococcal/*immunology/metabolism/pathology, PPAR gamma/metabolism, Receptors, Immunologic/genetics/*metabolism, Respiratory Mucosa/cytology/*immunology/metabolism/pathology, Survival Analysis
Date Added 2018/11/14 - 11:48:35
Date Modified 2019/05/14 - 20:58:31
Notes and Attachments (Note)
(Note)
24945405 (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés